Precigen, Inc. (PGEN)
4.38
-0.13
(-2.88%)
USD |
NASDAQ |
Feb 20, 16:00
4.38
0.00 (0.00%)
After-Hours: 20:00
Precigen SG&A Expense (Quarterly) : 23.99M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 1.024M |
| Amneal Pharmaceuticals, Inc. | 137.82M |
| Corcept Therapeutics, Inc. | 123.98M |
| ADMA Biologics, Inc. | 23.05M |
| Viridian Therapeutics, Inc. | 24.32M |